Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Prospective Validation of the Movement Disorder Society Prodromal Multiple System Atrophy Criteria in Pure Autonomic Failure.

Movement disorders : official journal of the Movement Disorder Society·2026

Same author

Cognitive correlates of decision-making in Parkinson's disease: a systematic review.

Frontiers in aging neuroscience·2026

Same author

Shortened olfactory identification testing to differentiate parkinsonian syndromes.

Parkinsonism & related disorders·2026

Same author

Clinical telemonitoring and telerehabilitation of cognition in rare neurological diseases: a scoping review.

Journal of neurology·2026

Same author

Essential genetic testing in movement disorders - results from a Delphi study.

Parkinsonism & related disorders·2026

Same author

Indications, contraindications, and step-by-step methodology for performing carotid sinus massage in patients presenting with syncope : A scientific statement of an Ad Hoc Syncope Consortium endorsed by: the European Autonomic Society (EFAS), Gruppo Italiano Multidisciplinare Syncope (GIMSI) and European Geriatric Medicine Society (EuGMS).

Clinical autonomic research : official journal of the Clinical Autonomic Research Society·2026

Search research articles

Related Experiment Video

Updated: Jul 15, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Development and Validation of a Prognostic Model to Predict Overall Survival in Multiple System Atrophy.

Sabine Eschlboeck¹, Georg Goebel², Christine Eckhardt^1,3

¹Department of Neurology Innsbruck Medical University Innsbruck Austria.

Movement Disorders Clinical Practice

|September 29, 2023

Summary

A new nomogram predicts survival for Multiple System Atrophy (MSA) patients using clinical factors like age at onset and autonomic failure. This tool aids in personalized patient counseling and treatment strategies for MSA.

Keywords:

multiple system atrophy nomogram overall survival prediction model prognosis

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS

Published on: October 6, 2015

Related Experiment Videos

Last Updated: Jul 15, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

An R-Based Landscape Validation of a Competing Risk Model

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS

Published on: October 6, 2015

Area of Science:

Neurology
Clinical Prognostics
Medical Statistics

Background:

Multiple System Atrophy (MSA) is a neurodegenerative disorder with variable motor and autonomic symptoms.
Previous research identified clinical factors associated with reduced survival in MSA patients.

Purpose of the Study:

To develop a predictive risk model for patient survival based on initial clinical symptoms.
To enable personalized counseling for Multiple System Atrophy patients.

Main Methods:

Retrospective analysis of 210 MSA patients from 1999-2016.
Utilized Kaplan-Meier curves and penalized Cox regression for prognostic factor identification.
Developed and validated a nomogram for estimating 7-year survival probability.

Main Results:

Key predictors for survival included age at onset, falls, early autonomic failure (orthostatic hypotension, urogenital issues), and lack of levodopa response.
The predictive model demonstrated good performance (AUC >0.7) and calibration for 7-year survival.
Median survival in the study cohort was 7 years.

Conclusions:

A nomogram was developed to predict individual survival in MSA patients.
This tool can enhance patient counseling and inform treatment decisions.
The model's validation supports its utility in clinical practice.